US equities
|
SPCX
$160.57
▲+0.00%
MU
$1,035.84
▲+0.00%
AAPL
$340.42
▲+0.00%
NVDA
$230.48
▲+0.00%
SNDK
$1,609.46
▲+0.00%
AVGO
$360.14
▲+0.00%
LITE
$1,048.60
▲+0.00%
TSLA
$375.00
▲+0.00%
SPCX
$160.57
▲+0.00%
MU
$1,035.84
▲+0.00%
AAPL
$340.42
▲+0.00%
NVDA
$230.48
▲+0.00%
SNDK
$1,609.46
▲+0.00%
AVGO
$360.14
▲+0.00%
LITE
$1,048.60
▲+0.00%
TSLA
$375.00
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Cartesian Therapeutics, Inc. - Common Stock
(NQ:
RNAC
)
6.820
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cartesian Therapeutics, Inc. - Common Stock
Cartesian Therapeutics Announces New Employment Inducement Grants
May 06, 2024
From
Cartesian Therapeutics, Inc.
Via
Business Wire
Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting
April 22, 2024
From
Cartesian Therapeutics, Inc.
Via
Business Wire
Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 04, 2024
From
Cartesian Therapeutics, Inc.
Via
Business Wire
Cartesian Therapeutics Announces New Employment Inducement Grants
April 04, 2024
From
Cartesian Therapeutics
Via
Business Wire
